171 - 180 of 8808 Results
Title
Year
-
RESTRICTEDTitle: Risk of Chronic Cardiomyopathy Among Patients With the Acute Phase or Indeterminate Form of Chagas DiseaseJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 3Issue #: 8Start Page: e2015072End Page: e2015072Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2020.15072Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2770045/chadalawada_2020_oi_200567_1602703565.56257.pdfCitation Count: 50
-
RESTRICTEDTitle: LRRK2 Phosphorylation, More Than an EpiphenomenonJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00527Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00527/pdfCitation Count: 41
-
RESTRICTEDTitle: Clinical implications of gastric complications on levodopa treatment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 76Issue #:Start Page: 63End Page: 71Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.001Best OA location URL: http://www.prd-journal.com/article/S1353802020301103/pdfCitation Count: 42
-
RESTRICTEDTitle: Excitotoxicity Revisited: Mitochondria on the Verge of a Nervous BreakdownJournal Name: Trends in NeurosciencesPublisher: Elsevier BVVol: 44Issue #: 5Start Page: 342End Page: 351Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.tins.2021.01.001Best OA location URL: https://discovery.ucl.ac.uk/10122786/9/Duchen_071220_Plotegher%20et%20al._final.pdfCitation Count: 28
-
RESTRICTEDTitle: The Evolution-Driven Signature of Parkinson’s DiseaseJournal Name: Trends in NeurosciencesPublisher: Elsevier BVVol: 43Issue #: 7Start Page: 475End Page: 492Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.tins.2020.05.001Best OA location URL: https://doi.org/10.1016/j.tins.2020.05.001Citation Count: 23
-
RESTRICTEDTitle: Multidisciplinary Care to Optimize Functional Mobility in Parkinson DiseaseJournal Name: Clinics in Geriatric MedicinePublisher: Elsevier BVVol: 36Issue #: 1Start Page: 159End Page: 172Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cger.2019.09.008Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/214080/214080.pdfCitation Count: 19
-
RESTRICTEDTitle: BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancerJournal Name: Lung CancerPublisher: Elsevier BVVol: 146Issue #:Start Page: 78End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.lungcan.2020.05.018Citation Count: 25
-
RESTRICTEDTitle: Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global reviewJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 11Start Page: 3947End Page: 3960Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10588-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10588-5.pdfCitation Count: 28
- Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments2021RESTRICTEDTitle: Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New TreatmentsJournal Name: Archives of Medical ResearchPublisher: Elsevier BVVol: 52Issue #: 3Start Page: 243End Page: 251Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arcmed.2020.10.021Citation Count: 25
-
RESTRICTEDTitle: Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and DevelopmentJournal Name: Therapeutic Innovation & Regulatory SciencePublisher: Springer Science and Business Media LLCVol: 54Issue #: 1Start Page: 103End Page: 116Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s43441-019-00034-0Citation Count: 27